The Union Ministry of Health and Family Welfare informed on Monday that the government has so far administered 220.05 crore vaccine doses under the Nationwide Vaccination Drive, of which 29,818 were administered in the last 24 hours.
In view of a global upsurge in cases of Corona, Odisha State Health Secretary Shalini Pandit on Friday wrote to the Central government asking for the re-commencing of COVID-19 precaution dose vaccination of the citizens who are "left out" and are 18 years or above in the state.
"I appeal to the people of Karnataka to take the booster dose at the earliest. People should wear masks, especially in indoor places and maintain social distancing," K Sudhakar said.
Bharat Biotech's nasal vaccine - iNCOVACC has been approved by the Government of India and will be used as a heterologous booster dose for those above 18 years of age
Union Civil Aviation Minister Jyotiraditya Scindia on Friday highlighted the ongoing vaccination drive, launched by the Centre government, against Covid-19 amid the fear of a covid surge in the Country.
"BF.7 is the sub-variant of Omicron. Its cases have increased in some countries including China, South Korea, Japan, Brazil and the USA since last week. There are four cases of BF.7 in India from Odisha and Gujarat which are the cases of the previous month. No cases of the BF.7 variant of Om
Chief Minister Pushkar Singh Dhami on Thursday staged a meeting at the Secretariat to direct the officers to launch a campaign to install booster doses in the state for effective control of COVID-19.
"China is witnessing more hospitalisation. Therefore we need to focus on booster dose coverage. Measures have been taken to send samples for genomic sequencing to trace new variants as per the centre's guidelines. A high-level meeting will be chaired by the Chief Minister to discuss the next
Viral infections rise in winter and better care needs to be taken. It is important for people, especially high-risk groups, to protect themselves and take Covid-19 booster dose, said Dr Randeep Guleria on Wednesday.
This fixed-dose combination has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg), Pioglitazone (15 mg) and Metformin (500mg/1000mg) in a sustained release (SR) formulation, according to the company's statement. It offers patients with type 2 diabetes the con